Androgen receptor gene alterations in Finnish male breast cancer

Breast Cancer Research and Treatment

Volumn 77, Issue 2, 2003, Pages 167-170

  Syrjäkoski, Kirsi ^d   Hyytinen, Eija R ^d   Kuukasjärvi, Tuula ^d   Auvinen, Anssi ^a   Kallioniemi, Olli P ^b   Kainu, Tommi ^d   Koivisto, Pasi A ^c  

^a UNIVERSITY OF TAMPERE   (Finland)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d NONE

Author keywords

Androgen receptor; CAG repeat; Male breast cancer; Mutation; Polymorphism

Indexed keywords

ANDROGEN RECEPTOR; ARGININE; LEUCINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FINLAND; GENE MUTATION; GENETIC CODE; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC RISK; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE BREAST; PRIORITY JOURNAL; PROSTATE CANCER; SCANDINAVIA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; COHORT STUDIES; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RISK FACTORS;

EID: 12244303265     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021369508561     Document Type: Article

References (27)

1. Ravandi-Kashani F, Hayes TG: Male breast cancer: a review of the literature. Eur J Cancer 34: 1341-1347, 1998
2. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ögmundsdottir HM, Eyfjörd JE: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13: 117-119, 1996
3. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL: BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13: 123-125, 1996
4. Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E: High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Cancer Res 59: 995-998, 1999
5. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60: 313-319, 1997
6. Haraldsson K, Loman N, Zhang QX, Johannsson O, Olsson H, Borg Å: BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res 58: 1367-1371, 1998
7. Wooster R, Mangion J, Eeles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BA, Stratton MR: A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2: 132-134, 1992
8. Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Namer M, Cutuli BF, Pujol H, Sultan C: Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 2: 1799-1802, 1993
9. Giguere Y, Dewailly E, Brisson J, Ayotte P, Laflamme N, Demers A, Forest VI, Dodin S, Robert J, Rousseau F: Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 61: 5869-5874, 2001
10. Young IE, Kurian KM, Mackenzie MA, Kunkler IH, Cohen BB, Hooper ML, Wyllie AH, Steel CM: The CAG repeat within the androgen receptor gene in male breast cancer patients. J Med Genet 37: 139-140, 2000
11. Kwiatkowska E, Teresiak M, Lamperska KM, Karczewska A, Breborowicz D, Stawicka M, Godlewski D, Krzyzosiak WJ, Mackiewicz A: BRCA2 germline mutations in male breast cancer patients in the Polish population. Hum Murat 17: 73, 2001
12. Haapala K, Hyytinen ER, Roiha M, Laurila M, Rantala I, Helin HJ, Koivisto PA: Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide. Lab Invest 81: 1647-1651, 2001
13. Mitchell S, Abel P, Ware M, Stamp G, Lalani E: Phenotypic and genotypic characterization of commonly used human prostatic cell lines. BJU 85: 932-944, 2000
14. Mononen N, Syrjäkoski K, Matikainen M, Tammela TL, Schleutker J, Kallioniemi OP, Trapman J, Koivisto PA: Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene. Cancer Res 60: 6479-6481, 2000
15. Syvänen AC: Solid-phase minisequencing as a tool to detect DNA polymorphism. Methods Mol Biol 98: 291-298, 1998
16. Nordenskjöld A, Friedman E, Tapper-Persson M, Söderhäll C, Leviav A, Svensson J, Anvret M: Screening for mutations in candidate genes for hypospadias. Urol Res 27: 49-55, 1999
17. Batch JA, Williams DM, Davies HR, Brown BD, Evans BA, Hughes IA, Patterson MN: Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Genet 1: 497-503, 1992
18. Hiort O, Klauber G, Cendron M, Sinnecker GH, Keim L, Schwinger E, Wolfe HJ, Yandell DW: Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur J Pediatr 153: 317-321, 1994
19. Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber E, Lynch HT, Weber BL, Brown M: Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 64: 1371-1377, 1999
20. Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G: Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Inst 91: 961-966, 1999
21. Given HF, Radbourne R, Oag H, Merritt S, Barclay E, Hanby AM, Lamlum H, McGrath J, Curran C, Tomlinson IP: The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer. Eur J Cancer 36: 533-534, 2000
22. Yu H, Bharaj B, Vassilikos EJ, Giai M, Diamandis EP: Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. Breast Cancer Res Treat 59: 153-161, 2000
23. Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T, Eeles RA: CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer 85: 36-40, 2001
24. Menin C, Banna GL, De Salvo G, Lazzarotto V, De Nicolo A, Agata S, Montagna M, Sordi G, Nicoletto O, Chieco-Bianchi L, D'Andrea E: Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett 168: 31-36, 2001
25. Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ: The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study. Cancer Res 62: 1045-1049, 2002
26. Mononen N, Hyytinen ER, Ikonen T, Autio V, Haapala K, Rökman A, Matikainen MP, Tammela TLJ, Kallioniemi OP, Koivisto PA, Schleutker J: Androgen receptor CAG polymorphism and prostate cancer risk. Hum Genet, 111: 166-171, 2002
27. Lund A, Udd B, Juvonen V, Andersen PM, Cederquist K, Ronnevi LO, Sistonen P, Sorensen SA, Tranebjaerg L, Wallgren-Pettersson C, Savontaus ML: Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia. Eur J Hum Genet 8: 631-636, 2000